Prick Or Treat: A Case Of Systemic Reaction During Intradermal Tests With Beta-Lactams
May 2022
in “
European Journal of Dermatology
”
TLDR Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.
A 58-year-old man with a complex medical history, including schizophrenia, chronic alcoholism, diabetes, and hypertension, experienced a systemic reaction during intradermal testing with beta-lactams. This case highlighted the potential for severe hypersensitivity reactions in patients with a history of drug allergies, even when previous reactions were mild and resolved spontaneously. The incident underscored the importance of careful monitoring and preparedness for systemic reactions during allergy testing, particularly in individuals with multiple health issues.